ÂÜÀòÂÒÂ×

Lesley Ann Calhoun has an extensive background in finance and accounting, with experience in various roles and companies within the life sciences industry. Currently serving as EVP and Chief Financial Officer at Aligos Therapeutics and as a Board Member and Audit Committee Chair at Tango Therapeutics, Calhoun also holds positions as a Board Member at California Life Sciences Institute. With a B.S. in Accounting from San Francisco State University, Lesley has held high-level positions at companies such as Global Blood Therapeutics, Horizon Pharma plc, and Hyperion Therapeutics, showcasing their expertise in financial management and strategic planning.